Composition and methods of treatment using synergistically-enhanced supplementation
A method and compositions of treatment for improving metabolic performance using supplementation, comprising the step of applying a supplement formulation to a human subject via a selected administration route, the supplement formulation comprising therapeutically effective amounts of a plurality of medium-chain triglycerides, a plurality of amino acids, and zeatin. The plurality of medium-chain triglycerides may comprise caprylic acid, and the plurality of amino acids may comprise carnitine which may be provided in the form of L-carnitine fumarate.
1 . A method of treatment for improving metabolic performance using supplementation, comprising the step of:
applying a supplement formulation to a human subject via a selected administration route, the supplement formulation comprising therapeutically-effective amounts of:
a plurality of medium-chain triglycerides;
a plurality of amino acids; and
zeatin.
2 . The method of claim 1 , wherein the plurality of medium-chain triglycerides includes caprylic acid.
3 . The method of claim 1 , wherein the plurality of amino acids includes carnitine.
4 . The method of claim 3 , wherein the carnitine is provided in the form of L-carnitine fumarate.
5 . The method of claim 1 , wherein the plurality of amino acids includes a plurality of cetylated amino acids.
6 . The method of claim 5 , wherein the plurality of cetylated amino acids includes cetyl myristoleate.
7 . The method of claim 5 , wherein the plurality of cetylated amino acids includes cetylated alpha-linoleic acid.
8 . The method of claim 1 , wherein the therapeutically-effective amount of the plurality of medium-chain triglycerides is between 0.1 and 2 grams.
9 . The method of claim 1 , wherein the therapeutically-effective amount of the plurality of amino acids is between 0.1 and 1 grams.
10 . The method of claim 1 , wherein the therapeutically-effective amount of the zeatin is between 0.1 and 1 milligram per kilogram bodyweight of the human subject.
11 . The method of claim 1 , wherein the selected administration route comprises oral administration.
12 . The method of claim 1 , wherein the selected administration route comprises transdermal administration.
13 . The method of claim 9 , wherein the supplement formulation comprises an aqueous gel.
14 . A composition for oral supplementation, comprising:
an ingestible pill comprising, or capsule containing, therapeutically effective amounts of:
a plurality of medium-chain triglycerides;
a plurality of amino acids; and
zeatin.
15 . The composition of claim 14 , wherein the plurality of medium-chain triglycerides includes caprylic acid.
16 . The composition of claim 14 , wherein the plurality of amino acids includes carnitine.
17 . The composition of claim 16 , wherein the carnitine is provided in the form of L-carnitine fumarate.
18 . The composition of claim 14 , wherein the plurality of amino acids includes a plurality of cetylated amino acids.
19 . The composition of claim 18 , wherein the plurality of cetylated amino acids includes cetyl myristoleate.
20 . The composition of claim 18 , wherein the plurality of cetylated amino acids includes cetylated alpha-linoleic acid.
21 . The composition of claim 14 , wherein the therapeutically-effective amount of the plurality of medium-chain triglycerides is between 0.1 and 2 grams.
22 . The composition of claim 14 , wherein the therapeutically-effective amount of the plurality of amino acids is between 0.1 and 1 grams.
23 . The composition of claim 14 , wherein the therapeutically-effective amount of the plurality of zeatin is between 0.1 and 1 milligram per kilogram bodyweight of the human subject.
24 . A composition for transdermal supplementation, comprising:
an aqueous gel comprising therapeutically effective amounts of:
a plurality of medium-chain triglycerides;
a plurality of amino acids; and
zeatin.
25 . The composition of claim 24 , wherein the plurality of medium-chain triglycerides includes caprylic acid.
26 . The composition of claim 24 , wherein the plurality of amino acids includes carnitine.
27 . The composition of claim 26 , wherein the carnitine is provided in the form of L-carnitine fumarate.
28 . The composition of claim 24 , wherein the plurality of amino acids comprises a plurality of cetylated amino acids.
29 . The composition of claim 28 , wherein the plurality of cetylated amino acids includes cetyl myristoleate.
30 . The composition of claim 28 , wherein the plurality of cetylated amino acids includes cetylated alpha-linoleic acid.
31 . The composition of claim 24 , wherein the therapeutically-effective amount of the plurality of medium-chain triglycerides is between 0.1 and 2 grams.
32 . The composition of claim 24 , wherein the therapeutically-effective amount of the plurality of amino acids is between 0.1 and 1 grams.
33 . The composition of claim 24 , wherein the therapeutically-effective amount of the zeatin is between 0.1 and 1 milligram per kilogram bodyweight of the human subject.